EDAP TMS reported EUR29.84M in Cash and Equivalent for its fiscal quarter ending in December of 2024.





Cash And Equivalent Change Date
AngioDynamics USD 44.76M 9.33M Feb/2025
Boston Scientific USD 1.96B 690M Dec/2025
EDAP TMS EUR 29.84M 4.35M Dec/2024
Henry Schein USD 136M 9M Sep/2025
Medtronic USD 1.28B 9M Sep/2025
Plus Therapeutics USD 8.55M 2.45M Dec/2023
Veracyte USD 315.57M 96.07M Sep/2025